DeviceClearance

LIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus— 510(k) K213858

Substantially Equivalent

DiaSorin, Inc.

FDA 510(k) clearance K213858 for LIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus, Substantially Equivalent on 2022-07-26. Applicant: DiaSorin, Inc..

Clearance details

Applicant
DiaSorin, Inc.
Product code
Code NXO
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Stillwater, MN, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.